Chris J. Hebert

463 total citations
16 papers, 336 citations indexed

About

Chris J. Hebert is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Chris J. Hebert has authored 16 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Internal Medicine. Recurrent topics in Chris J. Hebert's work include Peripheral Artery Disease Management (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Aortic aneurysm repair treatments (3 papers). Chris J. Hebert is often cited by papers focused on Peripheral Artery Disease Management (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Aortic aneurysm repair treatments (3 papers). Chris J. Hebert collaborates with scholars based in United States and United Kingdom. Chris J. Hebert's co-authors include David E. Allie, Craig Walker, V. Antoine Keller, Mitchell D. Lirtzman, Charles H. Wyatt, Peter Fail, Raghotham Patlola, Muhammad A. Khan, Krishnamoorthy Vivekananthan and Muhammad Asad Khan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Annals of Thoracic Surgery and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Chris J. Hebert

16 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris J. Hebert United States 11 201 191 91 63 50 16 336
Hosam F. El-Sayed United States 13 300 1.5× 354 1.9× 66 0.7× 91 1.4× 31 0.6× 35 441
Tanner I. Kim United States 11 234 1.2× 131 0.7× 57 0.6× 42 0.7× 9 0.2× 40 280
Herman Schroë Belgium 14 603 3.0× 598 3.1× 72 0.8× 47 0.7× 52 1.0× 29 715
Haobo Su China 11 161 0.8× 117 0.6× 46 0.5× 19 0.3× 29 0.6× 46 259
C L McGuinness United Kingdom 9 177 0.9× 129 0.7× 97 1.1× 57 0.9× 8 0.2× 22 321
Michael Belkin United States 9 274 1.4× 234 1.2× 66 0.7× 163 2.6× 42 0.8× 20 423
Charles D. Franco United States 9 202 1.0× 175 0.9× 34 0.4× 89 1.4× 21 0.4× 20 315
Khusrow Niazi United States 14 627 3.1× 460 2.4× 104 1.1× 127 2.0× 19 0.4× 29 723
Michael J. Tullis United States 11 268 1.3× 432 2.3× 39 0.4× 81 1.3× 14 0.3× 14 520
Johannes Schuster Germany 10 439 2.2× 444 2.3× 72 0.8× 33 0.5× 52 1.0× 11 512

Countries citing papers authored by Chris J. Hebert

Since Specialization
Citations

This map shows the geographic impact of Chris J. Hebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris J. Hebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris J. Hebert more than expected).

Fields of papers citing papers by Chris J. Hebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris J. Hebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris J. Hebert. The network helps show where Chris J. Hebert may publish in the future.

Co-authorship network of co-authors of Chris J. Hebert

This figure shows the co-authorship network connecting the top 25 collaborators of Chris J. Hebert. A scholar is included among the top collaborators of Chris J. Hebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris J. Hebert. Chris J. Hebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rasco, Drew, Theresa Medina, Pippa Corrie, et al.. (2023). Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma. Cancer Chemotherapy and Pharmacology. 92(1). 15–28. 24 indexed citations
2.
Longino, August, et al.. (2021). Respiratory Mechanics in a Cohort of Critically Ill Subjects With COVID-19 Infection. Respiratory Care. 66(10). 1601–1609. 1 indexed citations
3.
Longino, August, et al.. (2021). Emergency department characteristics and associations with intensive care admission among patients with coronavirus disease 2019. SHILAP Revista de lepidopterología. 2(1). e12350–e12350. 5 indexed citations
4.
Allie, David E., et al.. (2009). 24-Carat Gold, 14-Carat Gold, or Platinum Standards in the Treatment of Critical Limb Ischemia:. Journal of Endovascular Therapy. 16(SupplementI). I–134. 17 indexed citations
5.
Allie, David E., et al.. (2009). Clinical insights into the use of embolic protection devices during lower extremity peripheral vascular interventions.. PubMed. 21(8). 418–22. 2 indexed citations
6.
Allie, David E., Mitchell D. Lirtzman, Charles H. Wyatt, et al.. (2007). Targeted Renal Therapy and Contrast-Induced Nephropathy During Endovascular Abdominal Aortic Aneurysm Repair:Results of a Feasibility Pilot Trial. Journal of Endovascular Therapy. 14(4). 520–527. 6 indexed citations
7.
Allie, David E., Mitchell D. Lirtzman, Charles H. Wyatt, et al.. (2007). Targeted Renal Therapy and Contrast-Induced Nephropathy during Endovascular Abdominal Aortic Aneurysm Repair: Results of a Feasibility Pilot Trial. Journal of Endovascular Therapy. 14(4). 520–527. 21 indexed citations
8.
Allie, David E., Chris J. Hebert, & Craig Walker. (2007). Multifactorial acute renal failure treated with percutaneous targeted renal therapy (TRT): a case of "dialysis rescue".. PubMed. 19(2). E27–30. 4 indexed citations
9.
Hebert, Chris J., et al.. (2005). A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.. PubMed. 17(8). 427–32. 16 indexed citations
10.
Allie, David E., Chris J. Hebert, Mitchell D. Lirtzman, et al.. (2005). Critical limb ischemia: a global epidemic.A critical analysis of current treatment unmasks the clinical and economic costs of CLI.. PubMed. 1(1). 75–84. 47 indexed citations
11.
Allie, David E., Chris J. Hebert, Mitchell D. Lirtzman, et al.. (2004). Novel treatment strategy for leg and sternal wound complications after coronary artery bypass graft surgery: Bioengineered Apligraf. The Annals of Thoracic Surgery. 78(2). 673–678. 17 indexed citations
12.
Allie, David E., Chris J. Hebert, Mitchell D. Lirtzman, et al.. (2004). Novel simultaneous combination chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb ischemia: The power‐pulse spray technique. Catheterization and Cardiovascular Interventions. 63(4). 512–522. 53 indexed citations
13.
Allie, David E., Chris J. Hebert, Mitchell D. Lirtzman, et al.. (2004). Continuous Tenecteplase Infusion Combined With Peri/Postprocedural Platelet Glycoprotein IIb/IIIa Inhibition in Peripheral Arterial Thrombolysis:Initial Safety and Feasibility Experience. Journal of Endovascular Therapy. 11(4). 427–435. 11 indexed citations
14.
Allie, David E., Chris J. Hebert, Mitchell D. Lirtzman, et al.. (2004). Intraoperative Innominate and Common Carotid Intervention Combined With Carotid Endarterectomy:A “True” Endovascular Surgical Approach. Journal of Endovascular Therapy. 11(3). 258–262. 45 indexed citations
15.
Allie, David E., Chris J. Hebert, & Craig Walker. (2004). Nitinol Stent Fractures in the SFA The biomechanical forces exerted on the SFA provide a "stiff " challenge to endovascular stenting.. 39 indexed citations
16.
Allie, David E., Mitchell D. Lirtzman, Charles H. Wyatt, et al.. (2003). Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions.. PubMed. 15(6). 334–42. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hosam F. El-Sayed Breakdown of academic impact, for papers by Tanner I. Kim Breakdown of academic impact, for papers by Herman Schroë Breakdown of academic impact, for papers by Haobo Su Breakdown of academic impact, for papers by C L McGuinness Breakdown of academic impact, for papers by Michael Belkin Breakdown of academic impact, for papers by Charles D. Franco Breakdown of academic impact, for papers by Khusrow Niazi Breakdown of academic impact, for papers by Michael J. Tullis Breakdown of academic impact, for papers by Johannes Schuster
Rankless by CCL
2026